# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA3182074 | SID170466326 | Ratio CC50/IC50 | = | 86.8 | ALA5232793 | ||||||
2. | ALA3182074 | SID170466326 | IC50 | = | 0.1 | uM | ALA5232792 | 7.00 | nM | Toxoplasma gondii | ||
3. | ALA3182074 | SID170466326 | AC50 | 22.387 | uM | ALA3562146 | inactive | nM | ||||
4. | ALA3182074 | SID170466326 | Ac50 | 22.387 | uM | ALA3562152 | inactive | uM | ||||
5. | ALA3182074 | SID170466326 | IC50 | > | 10 | uM | ALA3562139 | inactive | nM | |||
6. | ALA3182074 | SID170466326 | IC50 | > | 10 | uM | ALA3561991 | inactive | nM | |||
7. | ALA3182074 | SID170466326 | IC50 | = | 0.255 | uM | ALA3562069 | 6.59 | active | nM | ||
8. | ALA3182074 | SID170466326 | IC50 | = | 1.963 | uM | ALA3562043 | 5.71 | active | nM | ||
9. | ALA3182074 | SID170466326 | IC50 | = | 0.133 | uM | ALA3562021 | 6.88 | active | nM | ||
10. | ALA3182074 | SID170466326 | IC50 | = | 0.205 | uM | ALA3561996 | 6.69 | active | nM | ||
11. | ALA3182074 | SID170466326 | Ac50 | 44.668 | uM | ALA3561990 | inactive | uM | ||||
12. | ALA3182074 | SID170466326 | IC50 | = | 0.227 | uM | ALA3562027 | 6.64 | active | nM | ||
13. | ALA3182074 | SID170466326 | IC50 | > | 10 | uM | ALA3562026 | inactive | nM | |||
14. | ALA3182074 | SID170466326 | IC50 | > | 10 | uM | ALA3562024 | inactive | nM | |||
15. | ALA3182074 | SID170466326 | IC50 | = | 0.219 | uM | ALA3562124 | 6.66 | active | nM | ||
16. | ALA3182074 | SID170466326 | IC50 | = | 3.391 | uM | ALA3562123 | 5.47 | active | nM | ||
17. | ALA3182074 | SID170466326 | IC50 | > | 10 | uM | ALA3562115 | inactive | nM | |||
18. | ALA3182074 | SID170466326 | IC50 | > | 10 | uM | ALA3562120 | inactive | nM | |||
19. | ALA3182074 | SID170466326 | AC50 | 44.668 | uM | ALA3562119 | inactive | nM | ||||
20. | ALA3182074 | SID170466326 | Inhibition | = | -4.57 | % | ALA4303805 | % | Severe acute respiratory syndrome coronavirus 2 |